A Cell‐Free Platform Based on Nisin Biosynthesis for Discovering Novel Lanthipeptides and Guiding their Overproduction In Vivo

Lanthipeptides have extensive therapeutic and industrial applications. However, because many are bactericidal, traditional in vivo platforms are limited in their capacity to discover and mass produce novel lanthipeptides as bacterial organisms are often critical components in these systems. Herein,...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ran, Zhang, Yuchen, Zhai, Guoqing, Fu, Shuai, Xia, Yao, Hu, Ben, Cai, Xuan, Zhang, Yan, Li, Yan, Deng, Zixin, Liu, Tiangang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507342/
https://www.ncbi.nlm.nih.gov/pubmed/32995136
http://dx.doi.org/10.1002/advs.202001616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507342/
https://www.ncbi.nlm.nih.gov/pubmed/32995136
http://dx.doi.org/10.1002/advs.202001616

Ejemplares similares